Together these results demonstrate that CIP2A is a novel Oct4 target gene in normal and malignant stem cell-like cells, and that they are co-expressed in vivo in testicular cancers with characteristics of stem cell–like cell growth. The gene discussed is POU5F1; the disease is testicular cancer.